Item 4 Controls and Procedures 

Evaluation of Disclosure Controls and Procedures 

In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), the Company’s management evaluated, with the participation of the Company’s President and Chief Executive Officer and the Company’s Vice President - Chief Financial Officer, the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the quarter ended September 30, 2019.
Based upon their evaluation of these disclosure controls and procedures, the Company’s President and Chief Executive Officer and the Company’s Vice President – Chief Financial Officer concluded that, as of the date of such evaluation, the Company’s disclosure controls and procedures were effective.
Changes in Internal Control over Financial Reporting 

There was no change in the Company’s internal control over financial reporting that occurred during the quarter ended September 30, 2019 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
Table of Contents  

Part II – Other Information 

Item 2Unregistered Sales of Equity Securities and Use of Proceeds 

In February 2017, the Board of Directors authorized the repurchase of up to 400,000 shares of the Company’s Common Stock through February 2020.
The following table provides information about the Company's purchases during the quarter ended September 30, 2019 of equity securities that are registered by the Company pursuant to Section 12 of the Exchange Act.
Item 6 Exhibits 

EXHIBIT INDEX 



A management contract or compensatory plan or arrangement.
Table of Contents  

SIGNATURES 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
